SCHEMBL19081422

SCHEMBL19081422

c1ccc(-c2c3ccccc3c(-c3ccc4oc5c(ccc6c7cc8ccccc8cc7oc65)c4c3)c3ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.42
ESR2 Q92731 6/20 0.42
PLA2G2A P14555 3/20 0.37
PLA2G4A P47712 3/20 0.37
CYP1A1 P04798 4/20 0.36
CYP1A2 P05177 4/20 0.36
CYP1B1 Q16678 3/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 4/20 0.36
MAPT P10636 3/20 0.36
TSHR P16473 3/20 0.36
HSD17B10 Q99714 3/20 0.36
GLA P06280 2/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ERAP1 Q9NZ08 1/20 0.35
PLA2G10 O15496 1/20 0.35
ALDH1A1 P00352 3/20 0.35
ADORA2A P29274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081509 0.96 PLA2G2A (0.41) ESR1ESR2PLA2G2APLA2G4ACYP1A1
SCHEMBL19081698 0.91 MAPT (0.41) CYP1A2KDM4EHPGDMAPTALDH1A1
SCHEMBL30448082 0.91 ESR1 (0.46) ESR1ESR2PLA2G2APLA2G4ACYP1A1
SCHEMBL29511654 0.91 ESR1 (0.46) ESR1ESR2PLA2G2APLA2G4ACYP1A1
SCHEMBL29416710 0.91 ESR1 (0.46) ESR1ESR2PLA2G2APLA2G4ACYP1A1
SCHEMBL16067563 0.91 ESR1 (0.46) ESR1ESR2PLA2G2APLA2G4ACYP1A1
SCHEMBL23426927 0.90 ESR1 (0.43) ESR1ESR2PLA2G2APLA2G4ACYP1A1
SCHEMBL23427714 0.90 ESR1 (0.43) ESR1ESR2PLA2G2APLA2G4ACYP1A1
SCHEMBL31747799 0.90 ESR1 (0.45) ESR1ESR2PLA2G2APLA2G4ACYP1A1
SCHEMBL22907992 0.90 ESR1 (0.45) ESR1ESR2PLA2G2APLA2G4ACYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885PLA2G2A 4330/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885PLA2G2A 4330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.